Patents by Inventor Hae-Joon Park

Hae-Joon Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10619198
    Abstract: The present invention relates to a primer for PCR obtained by, directly or through inosine as a linker, linking a complementary nucleotide sequence or a complementary nucleotide sequence including a mis-matched nucleotide sequence to the 5?-terminal of a forward or reverse primer; and to a PCR method including a step of mixing a nucleic acid template in a PCR composition including the primer and then performing PCR on the mixture. The primer for PCR of the present invention includes a complementary nucleotide sequence or a mis-matched nucleotide sequence in a complementary nucleotide sequence, which is linked to the 5?-terminal thereof directly or via a linker, thereby lowering the sensitivity increase due to the increase in amplification products and reducing non-specifically occurring reactions in PCR.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: April 14, 2020
    Assignee: SD BIOSENSOR, Inc.
    Inventors: Yoo-Deok Won, Hae-joon Park, Sunyoung Lee
  • Publication number: 20180346999
    Abstract: The invention relates to an isothermal-based dual functional oligonucleotide containing quencher and reporter dye for an isothermal nucleic acid amplification and a method for nucleic acid amplification and measurement using the same. The present invention is directed to a method capable of obviating the need for an additional oligonucleotide, in addition to four to six types of oligonucleotides for a nucleic acid amplification reaction of LAMP, detecting the amount of fluorescence according to the amplification of the nucleic acid of target gene-specific sequence for DNA and RNA, enabling the detection also after the completion of the reaction, and detecting the amount of fluorescence in real-time. Therefore, the present invention allows simultaneous multiple tests by measuring the amount of fluorescence in one tube after the completion of the reaction or in real time while varying the reporter dye according to the target gene.
    Type: Application
    Filed: November 30, 2016
    Publication date: December 6, 2018
    Inventors: Yoo Deok WON, Hae Joon PARK, Hyo Jin SEONG, Mi Ae LIM, Sun Young LEE
  • Publication number: 20180187240
    Abstract: The present disclosure relates to a complementary double-stranded oligo, in which, for the amplification of a particular gene sequence, an inosine linker is linked to the 5?-terminus of a primer for the corresponding sequence, a sequence complementary to the primer is linked to the inosine linker, and at least one mis-matched nucleotide is included in the complementary sequence to form a bubble structure; in which, depending on the treatment temperature, at a predetermined temperature or lower, a single stranded oligo is turned into a double-stranded form to exist in an inactivation form, and at a predetermined temperature or higher, the oligo is activated into a single-stranded oligo; and in which, a fluorescent substance and a quenching material are attached to the oligo, so that the oligo can be applied as a primer or a probe, and thus only two oligos can realize the gene amplification and fluorescent signal real-time measurement with high specificity.
    Type: Application
    Filed: May 25, 2016
    Publication date: July 5, 2018
    Inventors: Yoo-Deok WON, Hae-Joon PARK, Hyo-Jin Seong, Sunyoung LEE
  • Publication number: 20180002746
    Abstract: The present invention relates to a primer for PCR obtained by, directly or through inosine as a linker, linking a complementary nucleotide sequence or a complementary nucleotide sequence including a mis-matched nucleotide sequence to the 5?-terminal of a forward or reverse primer; and to a PCR method including a step of mixing a nucleic acid template in a PCR composition including the primer and then performing PCR on the mixture. The primer for PCR of the present invention includes a complementary nucleotide sequence or a mis-matched nucleotide sequence in a complementary nucleotide sequence, which is linked to the 5?-terminal thereof directly or via a linker, thereby lowering the sensitivity increase due to the increase in amplification products and reducing non-specifically occurring reactions in PCR.
    Type: Application
    Filed: January 7, 2016
    Publication date: January 4, 2018
    Inventors: Yoo-Deok WON, Hae-joon PARK, Sunyoung LEE
  • Patent number: 9034603
    Abstract: The present invention relates to a dried composition for hot-start PCR, more precisely a dried composition for hot-start PCR with improved stability and long-term storagability which is characteristically prepared by the steps of preparing a reaction mixture by mixing an aqueous solution containing reaction buffer, MgCl2, 4 types of dNTPs, DNA polymerase with pyrophosphate and pyrophosphatase in a reaction tube; and drying the reaction mixture prepared above, a preparation method of the same and a method for amplifying nucleic acid using the same. The dried composition for hot-start PCR is added with pyrophosphate and pyrophosphatase together before drying, so that it can have improved stability and long-term storagability as well as convenience in use, compared with the conventional compositions for hot-start PCR. Therefore, this composition can be effectively used for hot-start PCR, multiplex PCR or real-time quantitative PCR.
    Type: Grant
    Filed: October 28, 2008
    Date of Patent: May 19, 2015
    Assignee: BIONEER CORPORATION
    Inventors: Seong-Youl Kim, Hyun Bae Kim, Hae-Joon Park, Han Oh Park
  • Patent number: 8530639
    Abstract: A method for isolating a nucleic acid from a biological sample includes applying particulate matter to promote co-aggregation and co-precipitation of insoluble aggregate by directly adding to the biological sample, adding to the biological sample in admixture with a cell lysis buffer, adding to the biological sample treated with a cell lysis buffer, adding to cell lysates in admixture with a buffer for forming denatured protein aggregate; or adding to cell lysates comprising the formed denatured protein aggregate. The particulate matter is selected from the group consisting of a material formed from an element of Ag, Fe, Ti, Al, Sn, Si, Cu, Mo, Ni, W or Zn, an oxide, a carbide, a nitride, a boride and a silicide thereof, and a mixture thereof, a polymer selected from PMMA (Poly Methyl MethAcrylate), polyethylene or polyurethane; and a mixture thereof. The insoluble aggregate comprises denatured protein aggregate and cell debris.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: September 10, 2013
    Assignee: Bioneer Corporation
    Inventors: Jong-Hoon Kim, Min Kim, Hae-Joon Park, Han Oh Park
  • Patent number: 8513399
    Abstract: The present invention relates to primers for PCR amplification comprising abasic parts within the primer sequences and a method for PCR amplification using the same. More precisely, the present invention relates to primers capable of amplifying different templates and having abasic parts complementary to mutated site or polymorphic site of template DNA and a method for PCR amplification comprising the steps of mixing the composition for PCR amplification comprising the primers with nucleic acid template; and performing PCR with the mixture. The primers for PCR amplification of the present invention contain abasic parts not having specific coding information in their nucleotide sequences, so that they can amplify different templates having mutated sites at the same time.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: August 20, 2013
    Assignee: Bioneer Corporation
    Inventors: Hyun Bae Kim, Seong Youl Kim, Jun Mo Gil, Hae Joon Park, Han Oh Park
  • Publication number: 20120135394
    Abstract: Provided are an apparatus for integrated real-time nucleic acid analysis and a method for detecting target a nucleic acid using the same, and more particularly an integrated real-time nucleic acid analysis for simultaneously performing qualitative analysis or quantitative analysis on genes from various kinds of plural biological samples and a method for detecting target a nucleic acid using the same. The apparatus for integrated real-time nucleic acid analysis and the method for detecting target a nucleic acid using the same according to the present invention, perform tests of various targets required from various samples through a single step promptly and accurately, and thus, can be efficiently used by hospitals or the like needing to rapidly diagnose diseases.
    Type: Application
    Filed: March 11, 2010
    Publication date: May 31, 2012
    Applicant: BIONEER CORPORATION
    Inventors: Yu-Jeong Kim, Wan-Lim Koo, Jong-Hoon Kim, Dae-Jin Jang, Jin-Cheol Seo, Seong-Youl Kim, Hae-Joon Park, Han Oh Park
  • Patent number: 8058007
    Abstract: Disclosed is a cyclic reverse transcription method, which comprises performing reverse transcription reaction in one or more cycles, each cycle comprising the steps of: (i) performing reaction with a reverse transcription reaction solution comprising template RNA, RNA-dependent DNA polymerase, a reaction buffer, primers for reverse transcription and dNTPs, and optionally, a stabilizer, at 10° C. to 40° C. and, (ii) performing reaction with the resultant reaction solution at 42° to 55° C.
    Type: Grant
    Filed: March 19, 2008
    Date of Patent: November 15, 2011
    Assignee: Bioneer Corporation
    Inventors: Hui Jeong Jeong, Min-Jung Kim, Hae-Joon Park, Han Oh Park
  • Publication number: 20110008845
    Abstract: The present invention relates to primers for PCR amplification comprising abasic parts within the primer sequences and a method for PCR amplification using the same. More precisely, the present invention relates to primers capable of amplifying different templates and having abasic parts complementary to mutated site or polymorphic site of template DNA and a method for PCR amplification comprising the steps of mixing the composition for PCR amplification comprising the primers with nucleic acid template; and performing PCR with the mixture. The primers for PCR amplification of the present invention contain abasic parts not having specific coding information in their nucleotide sequences, so that they can amplify different templates having mutated sites at the same time.
    Type: Application
    Filed: October 2, 2008
    Publication date: January 13, 2011
    Applicant: BIONEER CORPORATION
    Inventors: Hyun Bae Kim, Seong Youl Kim, Jun Mo Gil, Hae Joon Park, Han Oh Park
  • Publication number: 20100221786
    Abstract: Disclosed is a cyclic reverse transcription method, which comprises performing reverse transcription reaction in one or more cycles, each cycle comprising the steps of: (i) performing reaction with a reverse transcription reaction solution comprising template RNA, RNA-dependent DNA polymerase, a reaction buffer, primers for reverse transcription and dNTPs, and optionally, a stabilizer, at 10° C. to 40° G and, (ii) performing reaction with the resultant reaction solution at 42° to 55° C.
    Type: Application
    Filed: March 19, 2008
    Publication date: September 2, 2010
    Inventors: Hui Jeong Jeong, Min-Jung Kim, Hae-Joon Park, Han Oh Park
  • Publication number: 20100209973
    Abstract: The present invention relates to a dried composition for hot-start PCR, more precisely a dried composition for hot-start PCR with improved stability and long-term storagability which is characteristically prepared by the steps of preparing a reaction mixture by mixing an aqueous solution containing reaction buffer, MgCl2, 4 types of dNTPs, DNA polymerase with pyrophosphate and pyrophosphatase in a reaction tube; and drying the reaction mixture prepared above, a preparation method of the same and a method for amplifying nucleic acid using the same. The dried composition for hot-start PCR is added with pyrophosphate and pyrophosphatase together before drying, so that it can have improved stability and long-term storagability as well as convenience in use, compared with the conventional compositions for hot-start PCR. Therefore, this composition can be effectively used for hot-start PCR, multiplex PCR or real-time quantitative PCR.
    Type: Application
    Filed: October 28, 2008
    Publication date: August 19, 2010
    Applicant: Bioneer Corporation
    Inventors: Seong-Youl Kim, Hyun Bae Kim, Hae-Joon Park, Han Oh Park
  • Publication number: 20100197903
    Abstract: Disclosed are a method for isolating a nucleic acid using particulate matter and a composition therefor. The method comprises essentially the steps of adding a lysis buffer and a neutralization buffer to a biological sample sequentially, and centrifuging cell lysates for at least 10 minutes to separate a solution comprising the nucleic acid and insoluble aggregate comprising denatured protein aggregate and cell debris. The particulate matter is added to and participates in co-aggregation and co-precipitation of denatured protein aggregate and cell debris, and co-aggregates and co-precipitates denatured protein aggregate and cell debris within a much shortened time, thereby to shorten the time and to increase the yield for the isolation of a nucleic acid, compared with conventional methods.
    Type: Application
    Filed: December 11, 2007
    Publication date: August 5, 2010
    Inventors: Jong-Hoon Kim, Min Kim, Hae-Joon Park, Han Oh Park
  • Patent number: 6365727
    Abstract: The present invention relates to gene and peptide sequences of a diabetes-specific endogenous retrovirus which is derived from type 1 diabetes patients. In particular, the present invention relates to a whole genome of the diabetes-specific variant of endogenous retrovirus (ERV-9) purified from pancreatic tissues of type 1 diabetes (insulin-dependent diabetes mellitus [IDDM]) patients and its genes and peptide and their sequences, which can be used as a diagnosing reagent for type 1 diabetes and as an immunogen. The diabetes-specific retrovirus expressed exclusively in pancreatic beta cells was purified from deceased type 1 diabetes patients. Subsequently, the retroviral gene sequences were determined, and by analyzing the amino acid sequence of the peptide deduced from the gene, 21 domains of the peptide having hydrophilicity and immuno-dominancy were identified.
    Type: Grant
    Filed: July 22, 1998
    Date of Patent: April 2, 2002
    Assignee: Green Cross Vaccine Corporation
    Inventors: Ji-Won Yoon, Hee-Sook Jun, Hae-Joon Park, Jong Seong Ahn, Young-Ju Ha, Soo-Il Chung